Arunjyoti Bio Ventures Ltd Stock Price Today (NSE: ABVL)
Fundamental Score
Arunjyoti Bio Ventures Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Arunjyoti Bio Ventures Ltd share price today is ₹5.39, down 0.19% on NSE/BSE as of 18 June 2026. Arunjyoti Bio Ventures Ltd (ABVL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹140.90 (Cr). The 52-week high for ABVL share price is ₹12.71 and the 52-week low is ₹5.05. The company has a Return on Equity (ROE) of -10.66% and a debt-to-equity ratio of 0.71.
Arunjyoti Bio Ventures Ltd Share Price Chart — NSE/BSE Historical Performance
Arunjyoti Bio Ventures Ltd share price chart: -31.22% return over the past month. 52-week high ₹12.71, 52-week low ₹5.05.
Arunjyoti Bio Ventures Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹5.39 | ₹5.48 | ₹5.32 | ₹5.39 | 2.69L (Cr) | |
| ₹5.60 | ₹5.60 | ₹5.38 | ₹5.40 | 4.94L (Cr) | |
| ₹5.52 | ₹5.68 | ₹5.50 | ₹5.59 | 2.57L (Cr) | |
| ₹5.64 | ₹5.69 | ₹5.45 | ₹5.53 | 7.13L (Cr) | |
| ₹5.58 | ₹5.64 | ₹5.50 | ₹5.60 | 4.93L (Cr) | |
| ₹5.70 | ₹5.72 | ₹5.55 | ₹5.58 | 5.62L (Cr) | |
| ₹5.79 | ₹5.79 | ₹5.54 | ₹5.70 | 3.50L (Cr) | |
| ₹5.79 | ₹5.85 | ₹5.50 | ₹5.71 | 4.37L (Cr) | |
| ₹5.74 | ₹5.98 | ₹5.55 | ₹5.68 | 5.73L (Cr) | |
| ₹5.85 | ₹5.99 | ₹5.73 | ₹5.84 | 2.86L (Cr) |
Arunjyoti Bio Ventures Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹5.60 | ₹5.60 | ₹5.32 | ₹5.39 | -3.75% | |
| ₹6.56 | ₹7.17 | ₹5.45 | ₹5.59 | -14.79% | |
| ₹6.59 | ₹10.99 | ₹6.20 | ₹6.90 | +4.70% | |
| ₹8.00 | ₹8.38 | ₹5.67 | ₹6.43 | -19.63% | |
| ₹7.29 | ₹8.24 | ₹6.56 | ₹7.96 | +9.19% | |
| ₹8.40 | ₹8.40 | ₹6.38 | ₹7.07 | -15.83% | |
| ₹7.56 | ₹9.16 | ₹7.19 | ₹8.45 | +11.77% | |
| ₹11.49 | ₹12.44 | ₹7.95 | ₹7.95 | -30.81% | |
| ₹9.61 | ₹12.71 | ₹8.68 | ₹11.72 | +21.96% | |
| ₹6.94 | ₹11.19 | ₹6.80 | ₹10.11 | +45.68% | |
| ₹5.44 | ₹6.54 | ₹5.05 | ₹6.33 | +16.36% | |
| ₹6.64 | ₹6.64 | ₹5.46 | ₹5.55 | -16.42% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Micro-cap co-packing play is a lottery ticket built on a fragile turnaround story.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Arunjyoti Bio Ventures (ABVL) saw a 3.27% stake sale by Chennupati Sarath Kumar between March 23 and April 10, reducing his holding from 10.84% to 7.57%. ABVL commissioned a new jelly pouch production line for jelly pouches for Tata Consumer Products at its Telangana facility, starting commercial production on March 10. On April 10, 91%.
CORE STORY (THE REAL GAME)
ABVL is attempting a turnaround from its co-packing business, leveraging relationships with large players like Tata Consumer Products. The market is watching if they can scale this niche and convert it into consistent profitability.
- New production line commissioned for Tata Consumer Products
- Stock gained 3.91% on April 10
- Reported a net profit of ₹0.05 Cr in the latest quarter
- Significant order wins beyond Tata
- Consistent profitability for the next 2-3 quarters
- Improvement in free cash flow
- Micro/SME cap implies liquidity risk
- Negative free cash flow of ₹-54.08 Cr
- Stake sale by Chennupati Sarath Kumar
No FII/DII presence. Promoter holding stable at 47.64%.
Financial services sector is expected to grow, but ABVL's niche is highly competitive.
New jelly pouch production line commissioned for Tata Consumer Products.
No. Free Cash Flow 5Y: ₹-54.08 Cr.
If ABVL can demonstrate consistent profitability and improve its cash flow, the stock could re-rate. However, the current valuation is unsustainable without significant improvement.
Primary Thesis Risk
Inability to generate sustainable free cash flow will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Arunjyoti Bio Ventures Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Arunjyoti Bio Ventures Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ABVL across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Consistent Growth Track Record (32.84% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-10.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.03%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-459.09%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-15.91%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (0.59x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-54.08 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Arunjyoti Bio Ventures Ltd vs Other Financial Services Peers
Peer Comparison - Other Financial Services
Compare Arunjyoti Bio Ventures Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
18.9/100 | ₹5.39₹5 | ₹140.90₹140.90 | — — | -10.66%Poor -10.66% Poor | 4.03%Poor 4.03% Poor | 0.71Good 0.7 Good | — — | 32.84%Excellent 32.84% Excellent | 0.00% | |
Crisil LtdCrisil Ltd... CRISIL • 500092 | 64/100 | ₹3987.30₹3987 | ₹32833.08₹32833.08 | 43.82Average 43.8 Average | 27.81%Excellent 27.81% Excellent | 35.60%Excellent 35.60% Excellent | 0.11Excellent 0.1 Excellent | 14.43%Good 14.43% Good | 13.49%Good 13.49% Good | 0.56% |
RRPSemiconductorRRPSemiconducto... RRPS • 504346 | 21.2/100 | ₹11320.20₹11320 | ₹15422.64₹15422.64 | — — | 208.63%Excellent 208.63% Excellent | 80.21%Excellent 80.21% Excellent | 1.56Average 1.6 Average | 179.71%Excellent 179.71% Excellent | — — | 0.00% |
COLAB PLATFORMS LIMITEDCOLAB PLATFORMS... COLAB • 542866 | 53.3/100 | ₹153.55₹154 | ₹4011.66₹4011.66 | 864.58Average 864.6 Average | 12.36%Average 12.36% Average | 16.59%Good 16.59% Good | 0.00Excellent 0.0 Excellent | 79.86%Excellent 79.86% Excellent | 188.59%Excellent 188.59% Excellent | 0.01% |
Dhani Services LtdDhani Services ... DHANI • 532960 | 20.9/100 | ₹51.06₹51 | ₹3896.81₹3896.81 | 114.92Average 114.9 Average | -1.81%Poor -1.81% Poor | 1.39%Poor 1.39% Poor | 0.18Excellent 0.2 Excellent | — — | -32.89%Poor -32.89% Poor | 0.00% |
ALGOQUANTALGOQUANT... ALGOQUANT • 505725 | 6.9/100 | ₹56.73₹57 | ₹1689.95₹1689.95 | 102.86Average 102.9 Average | 37.55%Excellent 37.55% Excellent | 32.47%Excellent 32.47% Excellent | 0.24Excellent 0.2 Excellent | — — | — — | 0.00% |
LKP Finance LtdLKP Finance Ltd... LKPFIN • 507912 | 1.7/100 | ₹189.35₹189 | ₹1396.38₹1396.38 | — — | -0.17%Poor -0.17% Poor | -0.83%Poor -0.83% Poor | 0.06Excellent 0.1 Excellent | 14.57%Good 14.57% Good | -17.45%Poor -17.45% Poor | 0.00% |
Centrum Capital LtdCentrum Capital... CENTRUM • 501150 | 0/100 | ₹22.65₹23 | ₹1369.10₹1369.10 | — — | -57.60%Poor -57.60% Poor | 8.93%Poor 8.93% Poor | 37.49Poor 37.5 Poor | — — | 47.25%Excellent 47.25% Excellent | 0.00% |
67.9/100 | ₹912.60₹913 | ₹1086.24₹1086.24 | 32.77Average 32.8 Average | 28.60%Excellent 28.60% Excellent | 37.87%Excellent 37.87% Excellent | 0.00Excellent 0.0 Excellent | 94.13%Excellent 94.13% Excellent | 43.40%Excellent 43.40% Excellent | 1.94% | |
Prime Securities LtdPrime Securitie... PRIMESECU • 500337 | 49/100 | ₹284.70₹285 | ₹998.77₹998.77 | 30.04Average 30.0 Average | 19.46%Good 19.46% Good | 22.62%Excellent 22.62% Excellent | 0.01Excellent 0.0 Excellent | 34.59%Excellent 34.59% Excellent | 3.63%Average 3.63% Average | 0.51% |
39.1/100 | ₹290.00₹290 | ₹890.53₹890.53 | 39.02Average 39.0 Average | 25.18%Excellent 25.18% Excellent | 29.45%Excellent 29.45% Excellent | 0.27Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Other Financial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Crisil Ltd share price32833.08 Cr
- RRPSemiconductor share price15422.64 Cr
- COLAB PLATFORMS LIMITED share price4011.66 Cr
- Dhani Services Ltd share price3896.81 Cr
- ALGOQUANT share price1689.95 Cr
Arunjyoti Bio Ventures Ltd PE Ratio History
Historical price-to-earnings ratio for ABVL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹0.01 | ₹22.15 | 2158x |
| FY 2022 | ₹0.00 | ₹8.53 | 1722.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Arunjyoti Bio Ventures Ltd Quarterly Performance
Latest quarterly metrics for ABVL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-15.91%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-459.09%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
32.84%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Arunjyoti Bio Ventures Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ABVL — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Arunjyoti Bio Ventures Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Arunjyoti Bio Ventures Ltd (ABVL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Arunjyoti Bio Ventures Ltd
About ABVL (Arunjyoti Bio Ventures Ltd)
Arunjyoti Bio Ventures Ltd is a dynamic entity operating within the Other Financial Services sector, leveraging its unique position to foster growth and innovation. While its roots... are firmly planted in traditional financial instruments, the company is steadily expanding its portfolio to include investments in sustainable and ecologically responsible ventures. Based in Hyderabad, India, ABVL is committed to identifying and nurturing emerging businesses that demonstrate a commitment to both profitability and environmental stewardship. With a focus on strategic partnerships and long-term value creation, Arunjyoti Bio Ventures aims to be a catalyst for positive change, driving financial returns while contributing to a more sustainable future. Their approach is marked by careful due diligence and a commitment to supporting ventures throughout their lifecycle. ABVL differentiates itself through a keen understanding of the evolving financial landscape, particularly the growing importance of Environmental, Social, and Governance (ESG) factors. The company's investment philosophy centers on identifying opportunities that align with global sustainability goals, recognizing that responsible investing is not only ethically sound but also economically advantageous in the long run. They employ a team of experienced professionals with expertise in financial analysis, venture capital, and sustainable business practices. This combination of skills allows them to thoroughly assess the potential of various ventures, providing not only capital but also strategic guidance and operational support. ABVL's commitment extends beyond mere financial investment, emphasizing a collaborative approach to foster lasting success. Originally established in 1986 as Century 21st Portfolio Limited, Arunjyoti Bio Ventures underwent a strategic transformation in 2014, signaling a renewed focus on bio-related and sustainable ventures. This evolution reflects the company's proactive approach to adapting to changing market dynamics and embracing emerging opportunities. With a strong foundation built on years of financial experience, ABVL is well-positioned to navigate the complexities of the modern investment landscape. The company's commitment to innovation and its emphasis on long-term value creation make it a compelling partner for businesses seeking both financial support and strategic guidance. By bridging the gap between financial expertise and sustainable business practices, Arunjyoti Bio Ventures aims to shape a more prosperous and environmentally responsible future.
Company Details
Key Leadership
ABVL Share Price: Frequently Asked Questions
What is the current share price of Arunjyoti Bio Ventures Ltd?
Arunjyoti Bio Ventures Ltd (ABVL) trades at ₹5.39 on NSE and BSE. Market cap ₹140.90 (Cr). Educational data only.
What is the P/E ratio of Arunjyoti Bio Ventures Ltd?
Arunjyoti Bio Ventures Ltd has a P/E of N/Ax vs industry average 30.94x.
What is the Bull Run score for Arunjyoti Bio Ventures Ltd?
Arunjyoti Bio Ventures Ltd has a Bull Run score of 18.9/100 based on 25+ financial parameters.
Does Arunjyoti Bio Ventures Ltd pay dividends?
Arunjyoti Bio Ventures Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Arunjyoti Bio Ventures Ltd?
Arunjyoti Bio Ventures Ltd has ROE of -10.66%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Arunjyoti Bio Ventures Ltd?
Arunjyoti Bio Ventures Ltd has debt-to-equity of 0.71.
Is Arunjyoti Bio Ventures Ltd a good investment?
Bull Run gives Arunjyoti Bio Ventures Ltd a score of 18.9/100. This is not investment advice — consult a SEBI-registered advisor.